Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-054087
Filing Date
2022-05-02
Accepted
2022-05-02 07:03:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2213547d2_defa14a.htm DEFA14A 10418
2 GRAPHIC tm2213547d2_defa14aimg001.jpg GRAPHIC 156523
3 GRAPHIC tm2213547d2_defa14aimg002.jpg GRAPHIC 87449
  Complete submission text file 0001104659-22-054087.txt   347612
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40675 | Film No.: 22879349
SIC: 2834 Pharmaceutical Preparations